By Dr. Kamal Kant Kohli,Dr. Shravani Dali
Copyright medicaldialogues
A newly published study suggests that lower circulating irisin levels in patients with type 2 diabetes (T2DM) are associated with impaired renal function, hinting at irisin’s potential as a prognostic biomarker for diabetic nephropathy. Researchers analyzed serum irisin concentrations in a cohort of adults with T2DM and categorized them based on kidney function-ranging from normal to impaired glomerular filtration rate (GFR) or macroalbuminuria. The findings revealed a significant inverse relationship: lower irisin levels correlated with worse renal parameters. Patients with more advanced diabetic nephropathy exhibited notably lower irisin compared to those with preserved kidney function. The team controlled for confounding factors like age, body mass index, glycemic control, and duration of diabetes, reinforcing the robustness of this association. Why irisin? This myokine, released during muscle activity, has been linked to metabolic regulation, insulin sensitivity, and anti-inflammatory effects. Its reduction in the context of diabetic kidney disease suggests that declining irisin may mark worsening renal health or perhaps play a role in pathogenesis. If validated in larger and longitudinal studies, irisin could emerge as a valuable, minimally invasive biomarker-used to identify T2DM patients at high risk of progression to diabetic nephropathy and guide early intervention strategies. That said, the authors caution against overinterpretation: this observational study shows association, not causation. Further research is needed to determine optimal irisin thresholds, understand its biological role in renal pathology, and evaluate whether therapeutic modulation of irisin might halt or reverse nephropathy. Meanwhile, clinicians should continue to rely on established markers-like albuminuria and GFR-for monitoring kidney health. But spotting irisin’s promise opens a potential pathway to more personalized, predictive care in diabetic nephrology. Reference: [Authors unknown]. (2025). Lower serum irisin levels in type 2 diabetic patients with impaired renal function: A potential prognostic marker for diabetic nephropathy. PrimePubMed. https://ubmed.com/m/40786580 [API]
